The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


DV8WORM 50 mg/144 mg/200 mg Tablets for dogs



Duggan Veterinary Supplies LimitedVPA10400/001/001

Main Information

Trade NameDV8WORM 50 mg/144 mg/200 mg Tablets for dogs
Active SubstancesPraziquantel
Pyrantel embonate
Fenbendazole
Dosage FormTablet
Licence HolderDuggan Veterinary Supplies Limited
Licence NumberVPA10400/001/001

Group Information

ATC CodeQP52AA51 praziquantel, combinations
Therapeutic ClassEndoparasiticide
SpeciesDogs

Status

License statusAuthorised
Licence Issued27/05/2022
Legal StatusCAM: Companion Animal Medicine as defined in relevant national legislation

Documents

Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back